AR and pachyonychia congenita: Therefore, the aim of the present work is to describe the differences in rs-fMRI measures (ALFF, ReHo and FC) between a group of PC patients treated with ADT and a PC control group (not treated with ADT), both in the whole brain and in specific regions of interest with high expression of androgen receptors.